First, the tumor tissue microarray of 112 patients with NPC was stained with anti–HLA-DPB1 antibody by immunohistochemistry, and the expression of HLA-DP on tumor cells was quantified (Figure 8A). This evidence concerns the gene HLA-DPA1 and nasopharyngeal carcinoma.